Annual Accounts Payable
$5.05 M
+$4.14 M+458.41%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual accounts payable is currently $5.05 million, with the most recent change of +$4.14 million (+458.41%) on 31 December 2023. During the last 3 years, it has risen by +$4.91 million (+3611.76%). ACRV annual accounts payable is now at all-time high.ACRV Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.51 M
+$245.00 K+19.43%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly accounts payable is currently $1.51 million, with the most recent change of +$245.00 thousand (+19.43%) on 30 September 2024. Over the past year, it has increased by +$2000.00 (+0.13%). ACRV quarterly accounts payable is now -70.17% below its all-time high of $5.05 million, reached on 31 December 2023.ACRV Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +458.4% | +0.1% |
| 3 y3 years | +3611.8% | +56.2% |
| 5 y5 years | - | - |
ACRV Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +3611.8% | -70.2% | +66.6% |
| 5 y | 5 years | at high | +3611.8% | -70.2% | +66.6% |
| alltime | all time | at high | +3611.8% | -70.2% | +66.6% |
Acrivon Therapeutics Common Stock Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.51 M(+19.4%) |
| June 2024 | - | $1.26 M(-38.7%) |
| Mar 2024 | - | $2.06 M(-59.3%) |
| Dec 2023 | $5.05 M | $5.05 M(+235.6%) |
| Sept 2023 | - | $1.50 M(+18.7%) |
| June 2023 | - | $1.27 M(-7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $1.37 M(+52.0%) |
| Dec 2022 | $904.00 K(-6.2%) | $904.00 K(-54.3%) |
| Sept 2022 | - | $1.98 M(+3.9%) |
| June 2022 | - | $1.90 M(+97.3%) |
| Dec 2021 | $964.00 K(+608.8%) | - |
| Dec 2021 | - | $964.00 K |
| Dec 2020 | $136.00 K | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual accounts payable?
- What is the all time high annual accounts payable for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual accounts payable year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly accounts payable?
- What is the all time high quarterly accounts payable for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly accounts payable year-on-year change?
What is Acrivon Therapeutics Common Stock annual accounts payable?
The current annual accounts payable of ACRV is $5.05 M
What is the all time high annual accounts payable for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual accounts payable is $5.05 M
What is Acrivon Therapeutics Common Stock annual accounts payable year-on-year change?
Over the past year, ACRV annual accounts payable has changed by +$4.14 M (+458.41%)
What is Acrivon Therapeutics Common Stock quarterly accounts payable?
The current quarterly accounts payable of ACRV is $1.51 M
What is the all time high quarterly accounts payable for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly accounts payable is $5.05 M
What is Acrivon Therapeutics Common Stock quarterly accounts payable year-on-year change?
Over the past year, ACRV quarterly accounts payable has changed by +$2000.00 (+0.13%)